SCHEMBL1662286

SCHEMBL1662286

O=C1CCc2cnc(C(F)(F)F)nc2N1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.37
ULK1 O75385 5/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CRBN Q96SW2 2/20 0.36
IDH1 O75874 1/20 0.35
DDB1 Q16531 1/20 0.35
LCAT P04180 1/20 0.34
HTR1A P08908 2/20 0.34
DRD2 P14416 2/20 0.34
HTR2A P28223 2/20 0.34
NPC1 O15118 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15994053 0.85 KDR (0.40) KIF11PDE3BPDE3AIDH1LCAT
SCHEMBL18168295 0.75 IDH1 (0.42) PDE3BPDE3ACRBNIDH1HTR1A
SCHEMBL17541302 0.75 ITGAV (0.35)
SCHEMBL14042006 0.75 PDE3B (0.46) PDE3BPDE3ACRBNIDH1DDB1
SCHEMBL2574949 0.72 PDE3B (0.38) PDE3BPDE3ACRBNIDH1NPC1
SCHEMBL17164728 0.71 PDE3B (0.40) PDE3BPDE3ACRBNIDH1HTR1A
SCHEMBL2625476 0.69 PDE3B (0.41) PDE3BPDE3AIDH1LCAT
SCHEMBL2819230 0.69 IDH1 (0.39) PDE3BPDE3ACRBNIDH1HTR1A
SCHEMBL14020816 0.68 IDH1 (0.38) PDE3BPDE3ACRBNIDH1HTR1A
SCHEMBL3419723 0.67 CRBN (0.47) PDE3BPDE3ACRBNNPC1MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491032-A1 AKT INHIBITORS Eli Lilly and Company (US) 2012-08-29 EP disclosed
WO-2011050016-A1 AKT INHIBITORS ELI LILLY AND COMPANY (US) 2011-04-28 WO disclosed